1. MicroRNA-215 is a potential prognostic marker for cervical cancer
- Author
-
Yan Li, Fu-jin Shen, Ruo-yu Luo, and Hua Liang
- Subjects
Oncology ,Male ,medicine.medical_specialty ,Biomedical Engineering ,Stage II Cervical Cancer ,Uterine Cervical Neoplasms ,Biochemistry ,Disease-Free Survival ,Metastasis ,Biomaterials ,HeLa ,Mice ,Internal medicine ,Genetics ,medicine ,Biomarkers, Tumor ,Animals ,Humans ,Survival rate ,Earth-Surface Processes ,Aged ,Neoplasm Staging ,Cervical cancer ,biology ,Proportional hazards model ,business.industry ,Hazard ratio ,Middle Aged ,medicine.disease ,biology.organism_classification ,Prognosis ,Gene Expression Regulation, Neoplastic ,MicroRNAs ,Tumor progression ,Female ,business ,HeLa Cells - Abstract
Recently, microRNAs (miRNAs) have been shown to be involved in multiple biological pathways that can influence tumor progression and metastasis and they can serve as prognostic biomarkers in many cancers. The present study examined the prognostic significance of miR-215 in cervical cancer. The paraffin-embedded paired cervical scrape samples and tumor tissue samples from 302 patients with stage II cervical cancer were detected for the expression of miR-215 by using qRT-PCR. A miR-215-based classifier was established by using the Cox regression model. The prognostic and predictive accuracy of this classifier was determined in both the internal testing group of 138 patients, and the external independent group of 280 patients. Moreover, cervical cancer HeLa cells overexpressing miR-215 (HeLa-miR-215) were constructed and subcutaneously injected into the nude mice to examine the effect of miR-215 on tumor growth and metastasis in vivo. The results showed that the expression level of miR-215 was significantly higher in cervical cancer tissues than in paired normal tissues (P
- Published
- 2013